Kathryn Lang

Company: Guardant Health

Job title: Vice President, Outcomes and Evidence

Seminars:

10.15 | 7.15 Opportunities for Liquid Biopsy Across the Continuum of Care 10:15 am

With the successful clinical adoption of LBx in late stage cancer, attention is now turning to opportunities earlier in the patient journey Earlier stage cancers require integration of several biomarkers to deliver appropriate sensitivity Progress is being made to generate the evidence to support clinical adoption, but regulatory and reimbursement hurdles must also be overcomeRead more

day: Day One